Citations

Mayo Clinic

Showing 10 of 108523 citations.

Improving Clinical Trial Efficiency: Thinking outside the Box
Mandrekar, Sumithra J. , Dahlberg, Suzanne E. , Simon, Richard

American Society of Clinical Oncology Educational Book | May 26, 2015 | Volume: No volume available | Issue: 35 | Pages: e141-e147

10.14694/edbook_am.2015.35.e141 | PMID 25993165 Get It

Clinical trial design strategies have evolved over the past few years as a means to accelerate the drug development process so that the right therapies can be delivered to the right patients. Basket, umbrella, and adaptive enrichment strategies represent a class of novel designs for testing targeted therapeutics in oncology. Umbrella trials include a central infrastructure for screening and identification of patients, and focus on a single tumor type or histology with multiple subtrials, each testing a targeted therapy within a molecularly defined subset. Basket trial designs offer the possibility to include multiple molecularly defined subpopulations, often across histology or tumor types, but included in one cohesive design to evaluate the targeted therapy in question. Adaptive enrichment designs offer the potential to enrich for patients with a particular molecular feature that is predictive of benefit for the test treatment based on accumulating evidence from the trial. This review will aim to discuss the fundamentals of these design strategies, the underlying statistical framework, the logistical barriers of implementation, and, ultimately, the interpretation of the trial results. New statistical approaches, extensive multidisciplinary collaboration, and state of the art data capture technologies are needed to implement these strategies in practice. Logistical challenges to implementation arising from centralized assay testing, requirement of multiple specimens, multidisciplinary collaboration, and infrastructure requirements will also be discussed. This review will present these concepts in the context of the National Cancer Institute's precision medicine initiative trials: MATCH, ALCHEMIST, Lung MAP, as well as other trials such as FOCUS4.
Pain Management in Four‐Limb Amputation: A Case Report
Warner, Matthew A. , Moeschler, Susan M. , Hoelzer, Bryan C. , Warner, Nafisseh S. , Warner, Matthew A

Pain Practice | May 26, 2015 | Volume: 15 | Issue: 7 | Pages: No page available

10.1111/papr.12307 | PMID 26011696 Get It

AbstractAcute pain following amputation can be challenging to treat due to multiple underlying mechanisms and variable clinical responses to treatment. Furthermore, poorly controlled preoperative pain is a risk factor for developing chronic pain. Evidence suggests that epidural analgesia and peripheral nerve blockade may decrease the severity of residual limb pain and the prevalence of phantom pain after lower extremity amputation. We present the perioperative analgesic management of a patient with gangrene of the bilateral upper and lower extremities as a result of septic shock and prolonged vasopressor administration who underwent four‐limb amputation in a single procedure. A multimodal analgesic regimen was utilized, including titration of preoperative opioid and neuropathic pain agents, perioperative intravenous, epidural and peripheral nerve catheter infusions, and postoperative oral medication titration. More than 8 months postoperatively, the patient has satisfactory pain control with no evidence for phantom limb pain. To our knowledge, there have been no publications to date concerning analgesic regimens in four‐limb amputation.
Volumetric computed tomography analysis of the olfactory cleft in patients with chronic rhinosinusitis
Pallanch, John F., Sansoni, E. Ritter, Jones, Cameron , Lawrence, Lauren A., Schlosser, Rodney J. , Mace, Jess C. , Smith, Timothy L. , Soler, Zachary M. , Schlosser, Rodney J

International Forum of Allergy & Rhinology | May 26, 2015 | Volume: 5 | Issue: 9 | Pages: 846-854

10.1002/alr.21552 | PMID 26010298 Get It

BackgroundCommonly used computed tomography (CT) staging systems for chronic rhinosinusitis (CRS) focus on the sinuses and do not quantify disease in the olfactory cleft. The goal of the current study was to determine whether precise measurements of olfactory cleft opacification better correlate with olfaction in patients with CRS.MethodsOlfaction was assessed using the 40‐item Smell Identification Test (SIT‐40) before and after sinus surgery in adult patients. Olfactory cleft opacification was quantified precisely using three‐dimensional (3D), computerized volumetric analysis, as well as via semiquantitative Likert scale estimations at predetermined anatomic sites. Sinus opacification was also quantified using the Lund‐Mackay staging system.ResultsThe overall cohort (n = 199) included 89 (44.7%) patients with CRS with nasal polyposis (CRSwNP) and 110 (55.3%) with CRS without nasal polyposis (CRSsNP). The olfactory cleft opacified volume correlated with objective olfaction as determined by the SIT‐40 (Spearman's rank correlation coefficient [Rs] = −0.461; p < 0.001). The correlation was significantly stronger in the CRSwNP subgroup (Rs = −0.573; p < 0.001), whereas no appreciable correlation was found in the CRSsNP group (Rs = −0.141; p = 0.141). Correlations between sinus‐specific Lund‐Mackay CT scoring and SIT‐40 scores were weaker in the CRSwNP (Rs = −0.377; p < 0.001) subgroup but stronger in the CRSsNP (Rs = −0.225; p = 0.018) group when compared to olfactory cleft correlations. Greater intraclass correlations (ICCs) were found between quantitative volumetric measures of olfactory cleft opacification (ICC = 0.844; p < 0.001) as compared with semiquantitative Likert grading (ICC = 0.627; p < 0.001).ConclusionQuantitative measures of olfactory cleft opacification correlate with objective olfaction, with the strongest correlations seen in patients with nasal polyps.
Associations between teaching effectiveness scores and characteristics of presentations in hospital medicine continuing education
Ratelle, John T. , Wittich, Christopher M. , Yu, Roger , Newman, James S. , Jenkins, Sarah M. , Beckman, Thomas J. , Yu, Roger C

Journal of Hospital Medicine | May 26, 2015 | Volume: 10 | Issue: 9 | Pages: 569-573

10.1002/jhm.2391 | PMID 26014666 Get It

BACKGROUNDThere is little research regarding characteristics of effective continuing medical education (CME) presentations in hospital medicine (HM). Therefore, we sought to identify associations between validated CME teaching effectiveness scores and characteristics of CME presentations in the field of HM.DESIGN/SETTINGThis was a cross‐sectional study of participants and didactic presentations from a national HM CME course in 2014.MEASUREMENTSParticipants provided CME teaching effectiveness (CMETE) ratings using an instrument with known validity evidence. Overall CMETE scores (5‐point scale: 1 = strongly disagree; 5 = strongly agree) were averaged for each presentation, and associations between scores and presentation characteristics were determined using the Kruskal‐Wallis test. The threshold for statistical significance was set at P < 0.05.RESULTSA total of 277 out of 368 participants (75.3%) completed evaluations for the 32 presentations. CMETE scores (mean [standard deviation]) were significantly associated with the use of audience response (4.64 [0.16]) versus no audience response (4.49 [0.16]; P = 0.01), longer presentations (≥30 minutes: 4.67 [0.13] vs <30 minutes: 4.51 [0.18]; P = 0.02), and larger number of slides (≥50: 4.66 [0.17] vs <50: 4.55 [0.17]; P = 0.04). There were no significant associations between CMETE scores and use of clinical cases, defined goals, or summary slides.CONCLUSIONSTo our knowledge, this is the first study regarding associations between validated teaching effectiveness scores and characteristics of effective CME presentations in HM. Our findings, which support previous research in other fields, indicate that CME presentations may be improved by increasing interactivity through the use of audience response systems and allowing longer presentations. Journal of Hospital Medicine 2015;10:569–573. © 2015 Society of Hospital Medicine
ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection?
Nowakowski, Grzegorz S. , Czuczman, Myron S.

American Society of Clinical Oncology Educational Book | May 26, 2015 | Volume: No volume available | Issue: 35 | Pages: e449-e457

10.14694/edbook_am.2015.35.e449 | PMID 25993209 Get It

Personalized therapy for the treatment of patients with cancer is rapidly approaching and is an achievable goal in the near future. A substantial number of novel targets have been developed into therapeutic agents. There is a substantial variability to antitumor activity by novel therapeutics because of the unique heterogeneity and biology that exists both between and within lymphoma subtypes. Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). Approximately 40% of patients have refractory disease or disease that will relapse after an initial response, and the majority of patients with relapsed DLBCL will succumb to the disease. There are two major biologically distinct molecular subtypes of DLBCL: germinal center B-cell (GCB) and activated B-cell (ABC). ABC DLBCL is associated with substantially worse outcomes when treated with standard chemoimmunotherapy. In addition to GCB and ABC subtypes, double-hit lymphomas (approximately 5% to 10% of patients) and double-expressor lymphomas, which overexpress MYC and BCL2 protein, are aggressive DLBCLs and are also associated with a poor prognosis. Double-hit lymphomas have concurrent chromosomal rearrangements of MYC plus BCL2 (or less likely, BCL6). Advances in molecular characterization techniques and the development of novel agents targeting specific subtypes of DLBCL have provided a foundation for personalized therapy of DLBCL based on molecular subtype. A number of early clinical trials evaluating combinations of novel targeted agents with standard chemotherapy (R-CHOP) have been completed and have demonstrated the feasibility of this approach with encouraging efficacy. As such, molecular classification of DLBCL is not only important for prognostication, but moves to center stage for personalization of therapy for DLBCL.
Retraction: N, S co-doped graphene quantum dots from a single source precursor used for photodynamic cancer therapy under two-photon excitation
Liu, Xifeng , Xia, Jianfei , Bi, Sai , Xia, Yanzhi, Gui, Rijun , Jin, Hui , Wang, Zonghua , Zhang, Feifei , Yang, Min Jae , Xia, Yanzhi

Chemical Communications | May 26, 2015 | Volume: 51 | Issue: 49 | Pages: 10066-10066

10.1039/c5cc90244d | PMID 26008806 Get It

Retraction of ‘N, S co-doped graphene quantum dots from a single source precursor used for photodynamic cancer therapy under two-photon excitation’ by Rijun Gui et al. , Chem. Commun ., DOI: 10.1039/C4CC09280E.
Raman Microscopic Analysis of Internal Stress in Boron-Doped Diamond
Bennet, Kevin E. , Lee, Kendall, Tomshine, Jonathan R. , Sundin, Emma , Kruchowski, James, Durrer, William, Manciu, Bianca, Kouzani, Abbas Z. , Manciu, Felicia , Lee, Kendall H. , Kouzani, Abbas Z , Manciu, Felicia S

Materials | May 26, 2015 | Volume: 8 | Issue: 5 | Pages: 2782-2793

10.3390/ma8052782 Get It

Analysis of the induced stress on undoped and boron-doped diamond (BDD) thin films by confocal Raman microscopy is performed in this study to investigate its correlation with sample chemical composition and the substrate used during fabrication. Knowledge of this nature is very important to the issue of long-term stability of BDD coated neurosurgical electrodes that will be used in fast-scan cyclic voltammetry, as potential occurrence of film delaminations and dislocations during their surgical implantation can have unwanted consequences for the reliability of BDD-based biosensing electrodes. To achieve a more uniform deposition of the films on cylindrically-shaped tungsten rods, substrate rotation was employed in a custom-built chemical vapor deposition reactor. In addition to visibly preferential boron incorporation into the diamond lattice and columnar growth, the results also reveal a direct correlation between regions of pure diamond and enhanced stress. Definite stress release throughout entire film thicknesses was found in the current Raman mapping images for higher amounts of boron addition. There is also a possible contribution to the high values of compressive stress from sp2 type carbon impurities, besides that of the expected lattice mismatch between film and substrate.
Clinical Characteristics and Outcomes of Patients with and without Diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) Trial
MacDonald, Michael R. , She, Lilin , Doenst, Torsten , Binkley, Philip F. , Rouleau, Jean L. , Tan, Ru‐San , Lee, Kerry L., Miller, Alan B. , Szalewska, Dominika , Waclawiw, Myron A., Castelvecchio, Serenella , Adlbrecht, Christopher , Michler, Robert E. , Oh, Jae K. , Petrie, Mark C. , Sopko, George S. , Dąbrowski, Rafał , Velazquez, Eric J. , Petrie, Mark C

European Journal of Heart Failure | May 26, 2015 | Volume: 17 | Issue: 7 | Pages: 725-734

10.1002/ejhf.288 | PMID 26011509 Get It

Abstract Aims Hypothesis 1 of the Surgical Treatment for Ischemic Heart Failure (STICH) trial enrolled 1212 patients with an LVEF of ≤35% and CAD amenable to coronary artery bypass grafting (CABG). Patients were randomized to CABG and optimal medical therapy (MED) or MED alone. The objective was to assess whether or not patients with diabetes mellitus (DM) enrolled in the STICH trial would have greater benefit from CABG than patients without DM. Methods and results The characteristics and clinical outcomes of patients with and without DM randomized to CABG and MED or MED alone were compared. DM was present in 40%. At baseline, patients with DM had more triple vessel CAD, higher LVEF, and smaller left ventricular volumes. In patients with DM, the primary outcome of all-cause mortality occurred in 39% of patients in the MED group and 39% in the CABG group [hazard ratio (HR) with CABG 0.96, 95% confidence interval (CI) 0.73–1.26]. In patients without DM, the primary outcome occurred in 41% of patients in the MED group and 32% in the CABG group (HR with CABG 0.80, 95% CI 0.63–1.02). While numerically it would appear that the treatment effect of CABG is blunted in patients with DM, there was no significant interaction between DM and treatment group on formal statistical testing. Conclusions Patients with DM enrolled in the STICH trial had more triple vessel disease, smaller hearts, and higher LVEF than those without DM. CABG did not exert greater benefit in patients with DM.
Eicosapentaenoic acid but not docosahexaenoic acid restores skeletal muscle mitochondrial oxidative capacity in old mice
Lalia, Antigoni Z., Dasari, Surendra , Fitch, Mark , Lanza, Ian R. , Johnson, Matthew L. , Pallauf, Maximilian , Hellerstein, Marc K. , Lanza, Ian R

Aging Cell | May 26, 2015 | Volume: 14 | Issue: 5 | Pages: 734-743

10.1111/acel.12352 | PMID 26010060 Get It

SummaryMitochondrial dysfunction is often observed in aging skeletal muscle and is implicated in age‐related declines in physical function. Early evidence suggests that dietary omega‐3 polyunsaturated fatty acids (n‐3 PUFAs) improve mitochondrial function. Here, we show that 10 weeks of dietary eicosapentaenoic acid (EPA) supplementation partially attenuated the age‐related decline in mitochondrial function in mice, but this effect was not observed with docosahexaenoic acid (DHA). The improvement in mitochondrial function with EPA occurred in the absence of any changes in mitochondrial abundance or biogenesis, which was evaluated from RNA sequencing, large‐scale proteomics, and direct measurements of muscle mitochondrial protein synthesis rates. We find that EPA improves muscle protein quality, specifically by decreasing mitochondrial protein carbamylation, a post‐translational modification that is driven by inflammation. These results demonstrate that EPA attenuated the age‐related loss of mitochondrial function and improved mitochondrial protein quality through a mechanism that is likely linked with anti‐inflammatory properties of n‐3 PUFAs. Furthermore, we demonstrate that EPA and DHA exert some common biological effects (anticoagulation, anti‐inflammatory, reduced FXR/RXR activation), but also exhibit many distinct biological effects, a finding that underscores the importance of evaluating the therapeutic potential of individual n‐3 PUFAs.
Mystery Case: A 21-year-old man with visual loss following marijuana use
Whitlock, Julia B., Robinson, Glen T., Whitlock, Joseph P., Dredla, Brynn K., Barrett, Kevin M.

Neurology | May 25, 2015 | Volume: 84 | Issue: 21 | Pages: No page available

10.1212/wnl.0000000000001627 | PMID 26009564 Get It